371 related articles for article (PubMed ID: 29615039)
1. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.
Plucinski MM; Dimbu PR; Macaia AP; Ferreira CM; Samutondo C; Quivinja J; Afonso M; Kiniffo R; Mbounga E; Kelley JS; Patel DS; He Y; Talundzic E; Garrett DO; Halsey ES; Udhayakumar V; Ringwald P; Fortes F
Malar J; 2017 Feb; 16(1):62. PubMed ID: 28153004
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic response to four artemisinin-based combination therapies in Angola, 2021.
Dimbu PR; Labuda S; Ferreira CM; Caquece F; André K; Pembele G; Pode D; João MF; Pelenda VM; Nieto Andrade B; Horton B; Kennedy C; Svigel SS; Zhou Z; Morais JFM; Rosário Jd; Fortes F; Martins JF; Plucinski MM
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0152523. PubMed ID: 38421163
[TBL] [Abstract][Full Text] [Related]
4. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
[TBL] [Abstract][Full Text] [Related]
5. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
6. Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019.
Dimbu PR; Horth R; Cândido ALM; Ferreira CM; Caquece F; Garcia LEA; André K; Pembele G; Jandondo D; Bondo BJ; Nieto Andrade B; Labuda S; Ponce de León G; Kelley J; Patel D; Svigel SS; Talundzic E; Lucchi N; Morais JFM; Fortes F; Martins JF; Pluciński MM
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168604
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.
Dentinger CM; Rakotomanga TA; Rakotondrandriana A; Rakotoarisoa A; Rason MA; Moriarty LF; Steinhardt LC; Kapesa L; Razafindrakoto J; Svigel SS; Lucchi NW; Udhayakumar V; Halsey ES; Ratsimbasoa CA
Malar J; 2021 Nov; 20(1):432. PubMed ID: 34732201
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
[TBL] [Abstract][Full Text] [Related]
9. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016.
Diarra Y; Koné O; Sangaré L; Doumbia L; Haidara DBB; Diallo M; Maiga A; Sango HA; Sidibé H; Mihigo J; Nace D; Ljolje D; Talundzic E; Udhayakumar V; Eckert E; Woodfill CJ; Moriarty LF; Lim P; Krogstad DJ; Halsey ES; Lucchi NW; Koita OA
Malar J; 2021 May; 20(1):235. PubMed ID: 34034754
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
Plucinski MM; Talundzic E; Morton L; Dimbu PR; Macaia AP; Fortes F; Goldman I; Lucchi N; Stennies G; MacArthur JR; Udhayakumar V
Antimicrob Agents Chemother; 2015 Jan; 59(1):437-43. PubMed ID: 25367912
[TBL] [Abstract][Full Text] [Related]
12. High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.
Mandara CI; Francis F; Chiduo MG; Ngasala B; Mandike R; Mkude S; Chacky F; Molteni F; Njau R; Mohamed A; Warsame M; Ishengoma DS
Malar J; 2019 Mar; 18(1):99. PubMed ID: 30909922
[TBL] [Abstract][Full Text] [Related]
13. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
[TBL] [Abstract][Full Text] [Related]
14. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial Resistance.
Moriarty LF; Nkoli PM; Likwela JL; Mulopo PM; Sompwe EM; Rika JM; Mavoko HM; Svigel SS; Jones S; Ntamabyaliro NY; Kaputu AK; Lucchi N; Subramaniam G; Niang M; Sadou A; Ngoyi DM; Muyembe Tamfum JJ; Schmedes SE; Plucinski MM; Chowell-Puente G; Halsey ES; Kahunu GM
Am J Trop Med Hyg; 2021 Sep; 105(4):1067-1075. PubMed ID: 34491220
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania.
Kakolwa MA; Mahende MK; Ishengoma DS; Mandara CI; Ngasala B; Kamugisha E; Kataraihya JB; Mandike R; Mkude S; Chacky F; Njau R; Premji Z; Lemnge MM; Warsame M; Menard D; Kabanywanyi AM
Malar J; 2018 Oct; 17(1):369. PubMed ID: 30333022
[TBL] [Abstract][Full Text] [Related]
17. Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
Nji AM; Ali IM; Moyeh MN; Ngongang EO; Ekollo AM; Chedjou JP; Ndikum VN; Evehe MS; Froeschl G; Heumann C; Mansmann U; Ogundahunsi O; Mbacham WF
Malar J; 2015 Jan; 14():27. PubMed ID: 25626448
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial.
Beavogui AH; Camara A; Delamou A; Diallo MS; Doumbouya A; Kourouma K; Bouedouno P; Guilavogui T; Dos Santos Souza S; Kelley J; Talundzic E; Fofana A; Plucinski MM
Malar J; 2020 Jun; 19(1):223. PubMed ID: 32580771
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018.
Nhama A; Nhamússua L; Macete E; Bassat Q; Salvador C; Enosse S; Candrinho B; Carvalho E; Nhacolo A; Chidimatembue A; Saifodine A; Zulliger R; Lucchi N; Svigel SS; Moriarty LF; Halsey ES; Mayor A; Aide P
Malar J; 2021 Oct; 20(1):390. PubMed ID: 34600544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]